Table 2.
Change of FBG for different groups of rats (mmol/l).
| Group | 0 week | 4 weeks | 8 weeks | 12 weeks |
|---|---|---|---|---|
| Control | 5.2 ± 0.7 | 4.9 ± 0.6 | 4.8 ± 0.6 | 5.2 ± 0.6 |
| DN | 25.5 ± 1.4a | 25.3 ± 1.4a | 25.3 ± 2.0a | 26.2 ± 1.5a |
| DN + leflunomide | 24.8 ± 1.4a | 24.3 ± 1.4a | 23.7 ± 0.8a | 22.7 ± 0.8a |
| DN + benazepril | 26.3 ± 1.6a | 23.7 ± 0.8a | 24.0 ± 0.6a | 23.0 ± 0.9a |
| DN + leflunomide and benazepril | 26.5 ± 2.3a | 22.7 ± 1.5a,b | 22.0 ± 1.4a,b | 21.7 ± 1.0a,b |
a
p < .05, compared with the control group.
b
p < .05, compared with the DN group. 0 week means the time for successful establishment of the DN model.